LLA.L Stock - LungLife AI, Inc.
Unlock GoAI Insights for LLA.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
Visit WebsiteEarnings History & Surprises
LLA.LLatest News
Frequently Asked Questions about LLA.L
What is LLA.L's current stock price?
What is the analyst price target for LLA.L?
What sector is LungLife AI, Inc. in?
What is LLA.L's market cap?
Does LLA.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to LLA.L for comparison